Chemoinformaics analysis of Confusarin
Molecular Weight | 300.31 | nRot | 3 |
Heavy Atom Molecular Weight | 284.182 | nRig | 16 |
Exact Molecular Weight | 300.1 | nRing | 3 |
Solubility: LogS | -3.845 | nHRing | 0 |
Solubility: LogP | 3.408 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 3 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
No. of Oxygen atom | 5 | No. of Arom Bond | 16 |
nHA | 5 | APOL | 43.0687 |
nHD | 2 | BPOL | 21.2593 |
QED | 0.725 |
Synth | 2.422 |
Natural Product Likeliness | 1.333 |
NR-PPAR-gamma | 0.937 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.012 |
Pgp-sub | 0.004 |
HIA | 0.013 |
CACO-2 | -4.953 |
MDCK | 0.0000284 |
BBB | 0.026 |
PPB | 0.90452 |
VDSS | 0.473 |
FU | 0.125595 |
CYP1A2-inh | 0.973 |
CYP1A2-sub | 0.964 |
CYP2c19-inh | 0.407 |
CYP2c19-sub | 0.413 |
CYP2c9-inh | 0.481 |
CYP2c9-sub | 0.893 |
CYP2d6-inh | 0.563 |
CYP2d6-sub | 0.873 |
CYP3a4-inh | 0.461 |
CYP3a4-sub | 0.283 |
CL | 10.259 |
T12 | 0.592 |
hERG | 0.1 |
Ames | 0.689 |
ROA | 0.581 |
SkinSen | 0.944 |
Carcinogencity | 0.466 |
EI | 0.949 |
Respiratory | 0.79 |
NR-Aromatase | 0.637 |
Antiviral | Yes |
Prediction | 0.746299 |